In terms of the Company's Code for Prohibition of Insider Trading and The SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, Brawn Biotech has informed that the trading window for dealing in the securities of the Company shall remain closed from April 01, 2020 and will re-open after completion of 48 hours from the declaration of financial results for the fourth quarter and year ended 31st March, 2020. The same has been intimated to all directors, officers and designated employees of the Company.
The above information is a part of company's filings submitted to BSE.
